1 year return (CAGR)
46.04%
Biogen Inc Exchange (NASDAQ, USD)
BIIB
217.36
+0.21 (+0.10%)
HealthcareDrug Manufacturers - General
Loading...
3 year return (CAGR)
-5.96%
5 year return (CAGR)
-8.21%
10 year return (CAGR)
-2.57%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
32.12B
Price/Sales
3.23
Ent value
44.07B
Price/Book
1.70
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
38.46
PEG
42.73
Forward P/E
13.14
EPS growth
-18.69%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 221.00 |
| Daily high | 222.25 |
| Daily low | 215.56 |
| Daily Volume | 630K |
| All-time high | 438.43 |
| 1y analyst estimate | 236.22 |
| Beta | 0.16 |
| EPS (TTM) | 5.62 |
| Dividend per share | 0.00 |
| Ex-div date | 2 Feb 2017 |
| Next earnings date | 6 May 2026 |
Downside potential
Loading...
Downside potential data
| BIIB | S&P500 | |
| Current price drop from All-time high | -50.42% | -2.19% |
| Highest price drop | -90.00% | -56.47% |
| Date of highest drop | 30 Dec 1994 | 9 Mar 2009 |
| Avg drop from high | -35.51% | -10.69% |
| Avg time to new high | 40 days | 12 days |
| Max time to new high | 2888 days | 1805 days |
News
